Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection

Next Previous
X
Search
Trial Profile

Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 05 Apr 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Citric acid/lactic acid/potassium bitartrate (Primary)
  • Indications Chlamydial infections; Gonorrhoea
  • Focus Registrational; Therapeutic Use
  • Acronyms AMPREVENCE
  • Sponsors Evofem Biosciences

    • Most Recent Events

    • 31 Mar 2022 Results published in an Evofem Biosciences Media Release
    • 30 Nov 2021 According to an Evofem Biosciences media release, the manuscript of this study were published in March 2021 in the American Journal of Obstetrics and Gynecology (AJOG).
    • 16 Sep 2021 According to an Evofem Biosciences media release, these abstracts will be published online in the Fertility and Sterility Abstract Supplement in September 2021 and posters abstracts will also be available in the ASRM On-Demand Congress content.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top